Advertisement

Topics

Yes on Issue 2: EpiPen Maker Mylan Caught Overcharging Medicaid $1.2 Billion; Agrees to $465M Settlement with Feds

16:56 EDT 18 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Ethically-challenged drug company behind the EpiPen—which saw a 500% price increase over the past decade—agrees to a landmark $465 million settlement with the U.S. D.O.J. Mylan overcharged Medicaid by $1.2 billion b...

Other Sources for this Article

for Ohio Taxpayers for Lower Drug Prices
Dennis Willard, 614.209.8945
dennis@precisionnewmedia.com

NEXT ARTICLE

More From BioPortfolio on "Yes on Issue 2: EpiPen Maker Mylan Caught Overcharging Medicaid $1.2 Billion; Agrees to $465M Settlement with Feds"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...